Imperial College London: Two Research Associate positions available
Candidates should hold a relevant first degree in Chemical Engineering or Physical or Pharmaceutical Sciences and hold or be near completion of a PhD (or equivalent) in Chemical Engineering, Chemistry, Pharmaceutics, Biochemistry, or a related discipline. Further information HERE
Deadline for abstracts is now Friday 13 November 2020 – Register HERE
BioProNET was granted a no-cost extension by the BBSRC to run until the end of August 2019. We have been investigating mechanisms by which to sustain the network beyond August 2019, and in particular to hold a Science Meeting in 2020.
Due to data protection rules, we are not allowed to use our BioProNET mailing list once funding for the network has finished.
If you arrived at this page not through an email link but would like to stay in touch please contact Jo Joanne.flannelly@manchester.ac.uk
The Principal Hotel, Manchester
June 3-4th 2019
Our flagship science meeting this year reflected on the science that has been developed to date through BioProNET support, and also provide a forward vision of the science that will underpin the next 10 years of bioprocessing.
| 10.00 | Registration |
| The Cell Factory: Proteins are go
co-chaired by Emma Hargreaves and Mark Smales |
|
| 11.00 | Nicole Borth, University of Natural Resources and Life Sciences (BOKU), Vienna – CHO genome news: variation, phenotypes and control |
| 11.30 | Tobias von der Haar, University of Kent – Controlling bioprocessing parameters through efficient sequence design |
| 11.45 | Sarah Smith, University of Warwick – Exploiting electron microscopy to optimise protein and biologic expression systems |
| 12.00 | Anil Day, University of Manchester – A high-yield expression platform for manufacturing recombinant human growth factors |
| 12.15 | Jose Guterriez-Marcos, University of Warwick – Rapid production of high value biologics in plant cell cultures |
| 12.30 | Poster talks: Gizem Buldum, Imperial College London – Monitoring the effect of accessory proteins on a CHO-based cell-free protein synthesis factory
Théo Mozzanino, University of Kent – Engineering the CHO secretory pathway for enhanced secretory recombinant protein production |
| 12.40 | Douglas Browning, University of Birmingham – Playing a round with recombinant protein production: what is PAR for the course |
| 12.55 | Lunch |
| The Cell Factory: Nucleic acids are go chaired by Nicole Borth | |
| 14.00 | Uta Griesenbach, Imperial College London – Latest developments in cystic fibrosis gene therapy |
| 14.30 | Michael Plevin, University of York – DNA motor proteins for nanopore sequencing |
| 14:45 | Duygu Dikicioglu, University of Cambridge – Addressing challenges in pre-processing and mining bioprocess development data in biocatalyst manufacturing by machine learning |
| 15.00 | Lorna Ashton, Lancaster University – Raman spectroscopy and gene therapy |
| 15.15 | Poster talks: George Prout, Cobra Biologics – Optimisation of a scalable rAAV production process
Zoltán Kis, Imperial College London – Techno-economic analysis of emerging vaccine platform and production technologies |
| 15:25 | James Budge, University of Kent – Engineering of CHO cell lipid metabolism to enhance biotherapeutic protein production |
| 15.40 | Refreshment break, networking, posters |
| Beyond the Cell and into Manufacturing chaired by Gary Lye | |
| 16.10 | Nigel Robinson, Durham University – Protein metalation in Industrial Biotechnology: E3B BBSRC NIBB opportunities |
| 16.40 | Jon Sayers, University of Sheffield – Engineering nucleases for genetic engineering and diagnostic applications |
| 16.55 | Gary Montague, Teesside University – Improved preservation of biologics by continuous intensified lyophilisation |
| 17.10 | Hirra Hussain & Louis Darton, Universities of Manchester and Kent – The BBSRC-funded Strategic Training Awards for Research Skills (STARS): The Bioprocessing Training Programme |
| 17.25 | Mark Carver, Bio-Industry Association SIAC – Shaping the future: where next for bio-processing research? |
| 17.55 | Hotel check-in |
| 18.20 | Poster session and drinks reception |
| 20.00 | Conference dinner |
Day 2 – 4thJune
| New Approaches and Enabling Technologies chaired by Paul Dalby | |
| 8.45 | Paul Kellam, Kymab – Deep mining of antibody responses – picking your best therapeutic mAb or vaccine |
| 9.15 | James Winterburn, University of Manchester – Enhanced glycolipid production and separation: from bench to business with UKRI funding |
| 9.30 | Alan Goddard, Aston University – Separation of sub-micron biologicals using microfluidic devices |
| 9.45 | Mark Wass, University of Kent – In silico analysis of host cell protein impurities in antibody purification |
| 10.00 | Jim Warwicker, University of Manchester – Computational approaches to study biopharmaceutical stability and formulation |
| 10.15 | Poster talks: Cloé Legrand, University of Cambridge – MRI characterisation of a microscale parallel bioreactor
Guido Zampieri, Teesside University – Combining machine learning and metabolic modelling as a tool for bioprocess development |
| 10.25 | David Brockwell, University of Leeds – Assessing biopharmaceutical aggregation in vivo and in vitro |
| 10.55 | Refreshment break, networking, posters |
| The Future Should Not Be Unexpected chaired by Alan Dickson | |
| 11.25 | Damian Marshall, Cell and Gene Therapy Catapult – Cell and gene therapy manufacture: the emerging role for AI |
| 11.55 | Ray Field, AdaptImmune – Bioprocessing for autologous T cell therapy |
| 12.25 | Poster talks: Denis Calnan, Thermo Fisher Scientific – A high resolution accurate mass multi-attribute method for critical quality attribute monitoring & new peak detection
Vera Lukashchuk, Cobra Biologics – Development of analytical package for AAV vectors: focus on qPCR Tim Eyes, University of Manchester – GeneORator: Smart DNA library design to accelerate the identification of improved protein variants |
| 12.40 | Peter Levison, Pall Biotech – Operating in a changing landscape: future process development strategies |
| 13.10 | Prize presentation – Colin Miles, BBSRC |
| 13.15 | Lunch and meeting close |
UCB Job Opportunity
UCB are currently seeking a protein Biochemist with experience in antibody engineering and production to join a bispecific antibody engineering team. The role will focus on providing protein purification expertise and antibody engineering knowledge, to support the development of new antibody based therapeutic projects and technologies.
You will work as part of the team based at our world class research centre in Slough, UK.
This exciting opportunity in the UK for an experienced biochemist with knowledge of DSP. Follow the link to learn more. Deadline for applications is 31 Dec 2019.
Cobra Biologics Job Opportunity
As a leading international clinical and commercial manufacturer of biologics and pharmaceuticals, Cobra Biologics offers a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market. We take pride in manufacturing excellence and being a trusted provider, delivering what we promise and helping our customers to develop drugs for the benefit of patients.
We are currently seeking to recruit an experienced Scientist within the Innovation department at Keele, Staffordshire, UK. The position is a 12 month fixed term contract working on a UK Government funded project focused on the development of recovery and chromatography based purification processes for viral vectors. More details HERE
We are also seeking to recruit a Senior Scientist within the Innovation Department at Keele, Staffordshire, UK. The successful candidate will be responsible for biologics upstream process development. More details HERE
Applications should be sent in writing stating the appropriate reference number with full CV and current salary details via our website: www.cobrabio.com/jobs.
